glp 1 gip dual agonist lilly New findings from SURPASS-EARLY: A GIP/GLP‑1 receptor compared with intensified conventional care after two years of treatment in early type 2 diabetes. Learn more: https://t.co/W8ffAFhFtk TrimRX | GLP-1 vs GIP:

This case highlights the need for gradual insulin tapering and close monitoring while transitioning from insulin therapy to GIP/GLP-1 receptor agonists.

GLP1 drugs like Ozempic and Wegovy are transforming obesity and diabetes care

Learn how GLP-1 regulates glucose, weight, and cardiovascular health, with FDA-approved therapies like semaglutide and emerging treatment strategies.

#HealthNotHype #PatientSafety #GLP1 #HealthEquity #FDA #ObesityCare #EvidenceBasedMedicine #NMQF

Currently, only 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs

In the T2D study, HbA1c improved by 2.2%, with 82% of participants reaching HbA1c6.5%